FDA.reportPublic FDA data

Hepad S5

Manufacturer
YOUNGJIN Korean Medicine Clinic
Effective date
2023-12-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:05:16

Label at a glance#

ProductHepad S5
Active ingredientRHYNCHOPHYLLINE, MAGNOLOL
Label structure12 sections

Indications and uses

Parkinson's disease

Storage and handling

refrigerated storage protect from freezing keep tightly closed

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

rhynchophylline 400mg

albiflorin 300mg

magnolol 300mg

Purpose

OTC - PURPOSE SECTION

neuro protection

neuro protection

Anti-Oxidative

Uses

DOSAGE & ADMINISTRATION SECTION

  • Parkinson's disease

Warnings

WARNINGS SECTION

Warnings

Ask a doctor before use if you

OTC - ASK DOCTOR SECTION

  • have Liver and/or kidney abnormalities
  • are pregnant

Ask a doctor or phamacist before use

OTC - ASK DOCTOR/PHARMACIST SECTION

if you are taking a prescription drug

Stop use and ask a doctor

OTC - STOP USE SECTION

  • If abnormal symptoms last for more than 1 week

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Direction

INDICATIONS & USAGE SECTION

  • adults and 20 years of age and older:
  • take 3 capsules 1 hour before or after meals
  • Take 2 times a day , take with water
  • Up to 1 hour apart from the conventional medicine you are taking

Other information

STORAGE AND HANDLING SECTION

  • refrigerated storage
  • protect from freezing
  • keep tightly closed

Inactive ingredients

INACTIVE INGREDIENT SECTION

  • corynoxeine, isocorynoxeine, isorhynchophylline, geissochizine methyl ether
  • paeoniflorin, oxypaeoniflorin, benzoylpaeoniflorin
  • magnocurarine, honokiol, b-eudesmol, cryptomeridiol

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

82049-20182049-201

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
82049-201-012025-01-30C16284748780-1f386c64a-3d71-0266-e053-dadaa90a7c1a82049-201
82049-201-012023-12-20C16284748780-1f386c64a-3d71-0266-e053-dadaa90a7c1a82049-201
82049-201-012023-01-30C16284748780-1f386c64a-3d71-0266-e053-dadaa90a7c1a82049-201

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82049-201-01Hepad S542 g in 1 BOTTLECAPSULE422

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82049-201HEPAD S5 (RHYNCHOPHYLLINE, MAGNOLOL) CAPSULE [YOUNGJIN KOREAN MEDICINE CLINIC]2Legacy NDC, 1 package rows20231221_c5066933-fbfa-e74e-e053-2995a90a617b.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82049-20182049-201-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
NameUNIIKind
RHYNCHOPHYLLINE46BQ79VJ8DACTIB
.BETA.-EUDESMOL6R61524P48IACT
OXYPAEONIFLORA3A7O4NBD5SIACT
ISOCORYNOXEINEJ18B596D11IACT
ISORHYNCHOPHYLLINE7F4P99KHLJIACT
HONOKIOL11513CCO0NIACT
PEONIFLORIN21AIQ4EV64IACT
PROXIMADIOLY2KBV9FZ9MIACT
CORYNOXEINE27KIC0Q2VAIACT
MAGNOLOL001E35HGVFACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0cfcb22f-00af-53b9-e063-6294a90a6946c5066933-fbfa-e74e-e053-2995a90a617b2023-12-20WarningsExact identifier
spl id: 0cfcb22f-00af-53b9-e063-6294a90a6946
spl set id: c5066933-fbfa-e74e-e053-2995a90a617b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.